Digital Repository

Assessing and Implementing Non-Prescription Treatments for Major Depressive Disorder

Show simple item record

dc.contributor.author Crawford, Rachel
dc.date.accessioned 2021-07-14T19:08:34Z
dc.date.available 2021-07-14T19:08:34Z
dc.date.created 2020
dc.identifier.uri http://hdl.handle.net/11216/3740
dc.description 2020 Celebration of Student Research and Creativity presentation en_US
dc.description.abstract Major Depressive Disorder is a mental health disorder that is classified as a prolonged depressed mood and loss of interest or pleasure in activities that were once enjoyed. Treatments vary per case and typically consist of a prescription drug to combat the disorder. In the US, MDD currently affects females at 8.7% and males at 5.3% (Major Depression). There are alternative treatments that could potentially aid patients. The pricing of treatment plans may be a factor in the treatment accessibility and feasibility. There’s a possibility that an increase in cognitive-behavioral therapy accessibility will lead to higher rates of MDD recovery. en_US
dc.description.uri https://youtu.be/y6g3RfH9Swc en_US
dc.language.iso en_US en_US
dc.publisher Northern Kentucky University en_US
dc.relation.ispartofseries Celebration of Student Research and Creativity;2020
dc.subject Depressive Disorder, Major en_US
dc.subject Therapeutics en_US
dc.title Assessing and Implementing Non-Prescription Treatments for Major Depressive Disorder en_US
dc.type Presentation en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record